Literature DB >> 5901509

The role of the liver in serum-induced hypercoagulability.

D Deykin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5901509      PMCID： PMC292690          DOI： 10.1172/JCI105338

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  ACTIVATION PRODUCT, FACTOR IX, SERUM THROMBOTIC ACCELERATOR ACTIVITY, AND SERUM-INDUCED THROMBOSIS.

Authors:  D DEYKIN; S WESSLER
Journal:  J Clin Invest       Date:  1964-02       Impact factor: 14.808

2.  ROLES OF SURFACE FACTOR AND A PLASMA INHIBITORY ACTIVITY (ANTI-SF) DURING EXPERIMENTAL THROMBOSIS IN RABBITS.

Authors:  S G IATRIDIS; P G IATRIDIS; J H FERGUSON
Journal:  Thromb Diath Haemorrh       Date:  1964-12-31

3.  Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis.

Authors:  S WESSLER
Journal:  J Clin Invest       Date:  1955-04       Impact factor: 14.808

4.  Studies on the in vivo behavior of blood coagulation product I in rats.

Authors:  T H SPAET
Journal:  Thromb Diath Haemorrh       Date:  1962-11-15

5.  The relation of factors XII, XI, and IX to hypercoagulable states.

Authors:  D P THOMAS; S WESSLER; S M REIMER
Journal:  Thromb Diath Haemorrh       Date:  1963-04-15

6.  Biologic assay of a thrombosis-inducing activity in human serum.

Authors:  S WESSLER; S M REIMER; M C SHEPS
Journal:  J Appl Physiol       Date:  1959-11       Impact factor: 3.531

7.  Serum-induced thrombosis. Studies of its induction, and evolution under controlled conditions in vivo.

Authors:  S WESSLER; L REINER; D G FREIMAN; S M REIMER; M LERTZMAN
Journal:  Circulation       Date:  1959-11       Impact factor: 29.690

8.  Effect of intravenous blood thromboplastin intermediates on clotting in rats.

Authors:  T H SPAET; M KROPATKIN
Journal:  Am J Physiol       Date:  1958-10

9.  A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases.

Authors:  S REITMAN; S FRANKEL
Journal:  Am J Clin Pathol       Date:  1957-07       Impact factor: 2.493
  9 in total
  10 in total

1.  Factor VIIa binding and internalization in hepatocytes.

Authors:  G Hjortoe; B B Sorensen; L C Petersen; L V M Rao
Journal:  J Thromb Haemost       Date:  2005-10       Impact factor: 5.824

2.  Dysfibrinogenemia associated with liver disease.

Authors:  J E Palascak; J Martinez
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

Review 3.  Local and systemic factors in the pathogenesis of thrombosis.

Authors:  D Deykin
Journal:  Calif Med       Date:  1970-03

4.  [Proceedings: Physiology of the coagulation mechanism (author's transl)].

Authors:  D L Heene
Journal:  Langenbecks Arch Chir       Date:  1973

Review 5.  Progress in disseminated intravascular coagulation.

Authors:  D G McKay
Journal:  Calif Med       Date:  1969-09

6.  [Endogenous inhibitors of fibrinolytic activity in liver cirrhosis (author's transl)].

Authors:  R Aschauer; F Holzknecht; S Platzer
Journal:  Klin Wochenschr       Date:  1973-12-01

7.  Fulminant hepatic failure secondary to congestive heart failure.

Authors:  B Kisloff; G Schaffer
Journal:  Am J Dig Dis       Date:  1976-10

8.  Intravascular fibrin deposits, hepatic infarcts and thrombocytopenia in parent/F mouse chimeras with host-versus-graft syndrome.

Authors:  R C Hard; W J Still
Journal:  Am J Pathol       Date:  1975-04       Impact factor: 4.307

9.  Metabolism of fibrinogen in cirrhosis of the liver.

Authors:  G N Tytgat; D Collen; M Verstraete
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

10.  Humoral factor that specifically regulates factor X levels in rabbits (coagulopoietin-X).

Authors:  D Trauber; K Hawkins; M Karpatkin; S Karpatkin
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.